# Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.

> **NCT04175301** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Stony Brook University** · enrollment: 15 (estimated)

## Conditions studied

- Malignant Glioma

## Interventions

- **DRUG:** Hydrogen
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04175301
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-10-31
- **Primary completion:** 2026-09-05
- **Final completion:** 2027-09-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04175301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04175301, "Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04175301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*